{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:38:21Z","timestamp":1790235501352,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.braindev.2009.11.009","type":"journal-article","created":{"date-parts":[[2009,12,24]],"date-time":"2009-12-24T04:10:32Z","timestamp":1261627832000},"page":"467-471","source":"Crossref","is-referenced-by-count":11,"title":["Tau proteins in the cerebrospinal fluid of patients with subacute sclerosing panencephalitis"],"prefix":"10.1016","volume":"32","author":[{"given":"Deniz","family":"Yuksel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neval Y.","family":"Uyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrin","family":"Senbil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavuz","family":"Gurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Anlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2009.11.009_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00023210-199707020-00003","article-title":"Subacute sclerosing panencephalitis: diagnosis and drug treatment options","volume":"7","author":"Anlar","year":"1997","journal-title":"CNS Drugs"},{"key":"10.1016\/j.braindev.2009.11.009_bib2","first-page":"133","article-title":"Neurofibrillary pathology in subacute sclerosing panencephalitis","volume":"2","author":"Wisniewski","year":"1991","journal-title":"Dementia"},{"key":"10.1016\/j.braindev.2009.11.009_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/0028-3886.30420","article-title":"Tau and taupathies","volume":"55","author":"Robert","year":"2007","journal-title":"Neurol India"},{"key":"10.1016\/j.braindev.2009.11.009_bib4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbadis.2004.09.008","article-title":"Tau pathology in Alzheimer disease and other tauopathies","volume":"1739","author":"Iqbal","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.braindev.2009.11.009_bib5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1602\/neurorx.1.2.213","article-title":"Cerebrospinal fluid protein biomarkers for Alzheimer\u2019s disease","volume":"1","author":"Blennow","year":"2004","journal-title":"NeuroRx"},{"key":"10.1016\/j.braindev.2009.11.009_bib6","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/brain\/awl269","article-title":"CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer\u2019s disease","volume":"129","author":"Buerger","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.braindev.2009.11.009_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10571-006-9370-z","article-title":"14-3-3 Protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt\u2013Jakob disease and neurodegenerative disease in Japan","volume":"26","author":"Satoh","year":"2006","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.braindev.2009.11.009_bib8","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/jnnp.70.5.624","article-title":"Both total and phosphorylated tau are increased in Alzheimer\u2019s disease","volume":"70","author":"Sjogren","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.braindev.2009.11.009_bib9","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1590\/S0004-282X2004000500001","article-title":"Hyperphosphorylated tau protein in the cerebrospinal fluid of patients with Alzheimer\u2019s disease and other dementias: preliminary findings","volume":"62","author":"Hartmann","year":"2004","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.braindev.2009.11.009_bib10","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1600-0404.1987.tb03598.x","article-title":"Creutzfeldt\u2013Jacob disease with plaques and paired helical filaments","volume":"76","author":"Liberski","year":"1987","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.braindev.2009.11.009_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neulet.2007.09.077","article-title":"Herpes simplex virus infection causes cellular \u03b2-amyloid accumulation and secretase up-regulation","volume":"429","author":"Wozniak","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.braindev.2009.11.009_bib12","first-page":"493","article-title":"SSPE: clinical staging, course, and frequency","volume":"32","author":"Jabbour","year":"1975","journal-title":"Arch Neurol"},{"key":"10.1016\/j.braindev.2009.11.009_bib13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ana.410110407","article-title":"Long term follow-up of patients with subacute sclerosing panencephalitis","volume":"11","author":"Dyken","year":"1982","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2009.11.009_bib14","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1212\/WNL.42.3.488","article-title":"Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis","volume":"42","author":"Yalaz","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2009.11.009_bib15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1177\/088307389701200611","article-title":"Mental assessment in subacute sclerosing panencephalitis: Hacettepe cognitive short assessment scale","volume":"12","author":"Oktem","year":"1997","journal-title":"J Child Neurol"},{"key":"10.1016\/j.braindev.2009.11.009_bib16","series-title":"Ankara developmental screening inventory handbook [Ankara Gelisimsel Tarama Envanteri El kitabi, AGTE]","author":"Savasir","year":"2005"},{"key":"10.1016\/j.braindev.2009.11.009_bib17","first-page":"50","article-title":"Besonderheiten der subakuten sklerosierenden leukoencephalitis im vergleich einiger deutscher und polnischer falle","volume":"5","author":"Schulze","year":"1967","journal-title":"Neuropatol Pol"},{"key":"10.1016\/j.braindev.2009.11.009_bib18","first-page":"557","article-title":"Sul quadro anatomo-isto-patologico della leucoencefalite sclerosante subacuta","volume":"18","author":"Gullotta","year":"1963","journal-title":"Acta Neurol"},{"key":"10.1016\/j.braindev.2009.11.009_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2990.1994.tb01168.x","article-title":"Association of measles virus with neurofibrillary tangles in subacute sclerosing panencephalitis: a combined in situ hybridization and immunocytochemical investigation","volume":"20","author":"McQuaid","year":"1994","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.braindev.2009.11.009_bib20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s15010-001-1115-9","article-title":"Changing epidemiological features of subacute sclerosing panencephalitis","volume":"29","author":"Anlar","year":"2001","journal-title":"Infection"},{"key":"10.1016\/j.braindev.2009.11.009_bib21","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.braindev.2006.04.008","article-title":"Subacute sclerosing panencephalitis: is there something different in the younger children?","volume":"28","author":"Yilmaz","year":"2006","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2009.11.009_bib22","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1097\/00003246-200212000-00015","article-title":"Role of serum S100B as an early predictor of high intracranial pressure and mortality in brain injury: Apilot study","volume":"30","author":"Petzold","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1016\/j.braindev.2009.11.009_bib23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(97)00701-5","article-title":"Increased S100beta in the cerebrospinal fluid of patients with frontotemporal dementia","volume":"235","author":"Green","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.braindev.2009.11.009_bib24","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/bmj.316.7131.577","article-title":"Diagnosis of Creutzfeldt\u2013Jakob disease by measurement of S100 protein in serum: prospective case control study","volume":"316","author":"Otto","year":"1998","journal-title":"BMJ"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760409003015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760409003015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T03:57:03Z","timestamp":1544759823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760409003015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0387760409003015"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2009.11.009","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}